Pharmacological characterization of ergotamine-induced inhibition of the cardioaccelerator sympathetic outflow in pithed rats

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 379, Issue 2, 2009, Pages 137-148

  Cobos Puc, Luis E ^a   Villalón, Carlos M ^a   Sánchez López, Araceli ^a   Ramírez Rosas, Martha B ^a   Lozano Cuenca, Jair ^a   Pertz, Heinz H ^b   Görnemann, Tilo ^b   Centurión, David ^a  

^a Cinvestav Coapa   (Mexico)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

2 Adrenoceptors; D2 like receptors; Ergotamine; Sympatho inhibition; Tachycardia

Indexed keywords

1,3,4,5',6,6',7,12B OCTAHYDRO 1',3' DIMETHYL 2H SPIRO[BENZO[B]FURO[2,3 A]QUINOLIZINE 2,4' PYRIMIDINE] 2' ONE; 2 (1 METHYL 2 ISOINDOLINYLMETHYL) 2 IMIDAZOLINE; DESIPRAMINE; ERGOTAMINE; GALLAMINE; HALOPERIDOL; METHOXAMINE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; NORADRENALIN; RAUWOLSCINE; SODIUM CHLORIDE;

ADRENERGIC STIMULATION; ANIMAL MODEL; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; EXPERIMENTAL MODEL; EXPERIMENTAL RAT; HEART FUNCTION; MALE; NONHUMAN; RAT; SPINAL ANIMAL; SYMPATHETIC TONE; WISTAR RAT;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; DECEREBRATE STATE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ERGOTAMINE; INFUSIONS, INTRAVENOUS; MALE; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTOR, SEROTONIN, 5-HT1D; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, DOPAMINE D2; SYMPATHETIC NERVOUS SYSTEM; TACHYCARDIA;

EID: 64949171638     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-008-0339-y     Document Type: Article

References (42)

1. 1 receptor subtype coupled to the inhibition of adenylate cyclase Proc Natl Acad Sci USA 90 408 412
2. SPH Alexander A Mathie JA Peters 2008 Guide to receptors and channels (GRAC), 3rd edn Br J Pharmacol 153 Suppl. 2 S1 S209
3. A Badia A Moron L Cuffi 1988 Effects of ergotamine on cardiovascular catecholamine receptors in the pithed rat Gen Pharmacol 19 475 481
4. 2B) in rat stomach fundus longitudinal muscle Br J Pharmacol 112 323 331
5. KJ Broadley KL Williamson AG Roach 1999 In vivo demonstration of α-adrenoceptor-mediated positive inotropy in pithed rats: evidence that noradrenaline does not stimulate myocardial α-adrenoceptors J Auton Pharmacol 19 55 63
6. D Centurión LE Cobos-Puc A Sánchez-López 2006 Receptor mechanisms involved in the cardiac sympatho-inhibition induced by ergotamine J Pharmacol Sci 101 Suppl I 27
7. Clark BJ, Chu D, Aelig WH (1978) Action on the heart and circulation in ergot alkaloids and related compounds. In: Berde B, Schild HO (eds) Handbook of experimental pharmacology. Springer-Verlag, Berlin-Heidelberg-New York
8. 2C- adrenoceptors mediate the inhibition of cardioaccelerator sympathetic outflow in pithed rats Eur J Pharmacol 554 205 211
9. JW Constantine RA Weeks WK McShane 1978 Prazosin and presynaptic alpha-receptors in the cardioaccelerator nerve of the dog Eur J Pharmacol 50 51 60
10. JS Gillespie A MacLaren D Pollock 1970 A method of stimulating different segments of the autonomic outflow from the spinal column to various organs in the pithed cat and rat Br J Pharmacol 40 257 267
11. E Glusa A Roos 1996 Endothelial 5-HT receptors mediate relaxation of porcine pulmonary arteries in response to ergotamine and dihydroergotamine Br J Pharmacol 119 330 334
12. 1- adrenoceptor subtypes Naunyn-Schmiedeberg's Arch Pharmacol 376 321 330
13. 2-dopamine antagonists on apomorphine-induced inhibition of peripheral sympathetic neurotransmission J Auton Pharmacol 8 297 302
14. Hoffmann BB (2001) Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Hardman JG, Limbird LE, Gilman AG (eds) Goodman and Gilman's the pharmacological basis of therapeutics. McGraw-Hill, New York
15. 1 recognition sites J Recept Res 8 59 81
16. D Hoyer DE Clarke JR Fozard 1994 International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin) Pharmacol Rev 46 157 203
17. 2-adrenergic receptors: agonist-mediated [35S]GTPgammaS binding Biochem Pharmacol 55 1035 1043
18. LI Kleinman EP Radford 1964 Ventilation standards for small mammals J Appl Physiol 19 360 362
19. Leysen JE, Gommeren W (1984) In vitro binding profile of drugs used in migraine. In: Amery WK, Van Nueten JM, Wauquier A (eds) The pharmacological basis of migraine therapy. Pitman Publishing Ltd, London
20. G Maurer W Frick 1984 Elucidation of the structure and receptor binding studies of the major primary, metabolite of dihydroergotamine in man Eur J Clin Pharmacol 26 463 470
21. 1- adrenoceptor subtypes mediating inotropic effects in rat right ventricle Br J Pharmacol 111 539 46
22. MJ Millan M Brocco JM Rivet 2000 S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents J Pharmacol Exp Ther 292 54 66
23. E Müller-Schweinitzer 1984 Pharmacological actions of the main metabolites of dihydroergotamine Eur J Clin Pharmacol 26 699 705
24. E Müller-Schweinitzer J Rosenthaler 1987 Dihydroergotamine: pharmacokinetics, pharmacodynamics, and mechanism of venoconstrictor action in beagle dogs J Cardiovasc Pharmacol 9 686 693
25. 1B/1D receptor antagonist GR 127,395 CNS Drug Rev 32 415 428
26. 1Dα receptor sites Neuropharmacology 34 235 237
27. 1D receptors Naunyn-Schmiedeberg's Arch Pharmacol 356 312 320
28. 2-adrenoceptor agonists in pithed rats J Pharmacol Exp Ther 240 944 953
29. 1-adrenergic antagonist activity of ergotamine and dihydroergotamine in rats Arch Int Pharmacodyn Ther 284 30 37
30. J Roquebert A Moran MF Sauvage 1992 Effects of quinpirole on autonomic nervous control of heart rate in rats Fundam Clin Pharmacol 6 67 73
31. 5A/5B receptors Br J Pharmacol 140 725 735
32. 1D subtypes Naunyn-Schmiedeberg's Arch Pharmacol 369 220 227
33. PR Saxena WI Cairo-Rawlins 1979 Presynaptic inhibition by ergotamine of the responses to cardioaccelerator nerve stimulations in the cat Eur J Pharmacol 58 305 312
34. RE Shipley JH Tilden 1947 A pithed rat preparation suitable for assaying pressor substances Proc Soc Exp Biol Med 64 453 455
35. SD Silberstein DC McCrory 2003 Ergotamine and dihydroergotamine: history, pharmacology, and efficacy Headache 43 144 166
36. Steel RGD, Torrie JH (1980) Principles and procedures of statistics: a biomedical approach. McGraw-Hill Kogakusha, Tokyo
37. P Tfelt-Hansen PR Saxena C Dahlof 2000 Ergotamine in the acute treatment of migraine: a review and European consensus Brain 123 9 18
38. 2C adrenoceptors J Pharmacol Exp Ther 271 1558 1565
39. 1-adrenoceptors mediate the external carotid vasoconstriction to ergotamine in vagosympathectomised dogs Naunyn-Schmiedeberg's Arch Pharmacol 370 46 53
40. D Vallone R Picetti E Borrelli 2000 Structure and function of dopamine receptors Neurosci Biobehav Rev 24 125 132
41. CM Villalón D Centurión MM Fernández 1999 5-Hydroxytryptamine inhibits the tachycardia induced by selective preganglionic sympathetic stimulation in pithed rats Life Sci 64 1839 1847
42. 2B) receptor Naunyn-Schmiedeberg's Arch Pharmacol 357 17 24